title: [Not Available].
authors.affiliation: EA2694, Université Lille 2 ; DRCI, CHRU de Lille, Lille, France. Electronic address: benoit.dervaux@chru-lille.fr.
authors.forename: Benoît
authors.initials: B
authors.lastname: Dervaux
authors.affiliation: Laboratoires Lilly, Neuilly sur Seine, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Baseilhac
authors.affiliation: CEPS, Ministère des affaires sociales et de la santé, Paris, France.
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Fagon
authors.affiliation: Laboratoire Novartis Pharma, Rueil Malmaison, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Ameye
authors.affiliation: DGCIS, Ministère du redressement productif, Paris, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Angot
authors.affiliation: Medtronic, Boulogne Billancourt, France.
authors.forename: Antoine
authors.initials: A
authors.lastname: Audry
authors.affiliation: AP-HP, CHU Paris Sud, Paris, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Becquemont
authors.affiliation: Laboratoire Sanofi-Aventis, Paris, France.
authors.forename: Thomas
authors.initials: T
authors.lastname: Borel
authors.affiliation: Laboratoires Lilly, Suresnes, France.
authors.forename: Béatrice
authors.initials: B
authors.lastname: Cazeneuve
authors.affiliation: Caisse nationale d'Assurance maladie, Paris, France.
authors.forename: Jocelyn
authors.initials: J
authors.lastname: Courtois
authors.affiliation: CEMKA-EVAL, Bourg la Reine, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Detournay
authors.affiliation: FEFIS, Boulogne, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Favre
authors.affiliation: Boston Scientific, Saint Quentin en Yvelines, France.
authors.forename: Muriel
authors.initials: M
authors.lastname: Granger
authors.affiliation: SNITEM, Courbevoie, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Josseran
authors.affiliation: Les entreprises du médicament, Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Lassale
authors.affiliation: DGOS, Ministère des affaires sociales et de la santé, Paris, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Louvet
authors.affiliation: AP-HP, Paris, France.
authors.forename: Jean
authors.initials: J
authors.lastname: Pinson
authors.affiliation: ESSEC, Cergy Pontoise, France.
authors.forename: Gérard
authors.initials: G
authors.lastname: de Pouvourville
authors.affiliation: Haute Autorité de Santé, Saint Denis la Plaine, France.
authors.forename: Lise
authors.initials: L
authors.lastname: Rochaix
authors.affiliation: Haute Autorité de Santé, Saint Denis la Plaine, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Rumeau-Pichon
authors.affiliation: Laboratoire MSD Chibret, Courbevoie, France.
authors.forename: Rima
authors.initials: R
authors.lastname: de Saab
authors.affiliation: Inserm, Paris, France.
authors.forename: Mickaël
authors.initials: M
authors.lastname: Schwarzinger
authors.affiliation: DGCIS, Paris, France.
authors.forename: Aristide
authors.initials: A
authors.lastname: Sun
keywords: accès au marché; commission d’évaluation économique et de santé publique; dispositifs médicaux innovants; efficience; impact budgétaire; médicamentsinnovants; prix des médicaments et dispositifs médicaux; rapport coût-efficacité; remboursement; référentiels; seuil d’acceptabilité; évaluation médico-économique